Market Tracker

09/27 9:54am ET

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

1.81
Delayed Data
As of 9:37am ET
 -0.03 / -1.63%
Today’s Change
1.26
Today|||52-Week Range
6.49
-52.62%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close1.84
Today’s open1.84
Day’s range1.81 - 1.85
Volume4,347
Average volume (3 months)54,140
Market cap$12.1M
Dividend yield--
Data as of 9:37am ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)+73.42%
Earnings growth (this year)+35.71%
Earnings growth (next 5 years)--
Revenue growth (last year)-52.11%
P/E ratioNM
Price/Sales558.44
Price/Book1.35

Competitors

 Today’s
change
Today’s
% change
XTNTXtant Medical Holdin...-0.08-7.14%
IGCIndia Globalization ...+0.00+0.66%
MATNMateon Therapeutics ...0.000.00%
BNTCBenitec Biopharma Lt...+0.03+2.13%
Data as of 9:34am ET, 09/27/2016

Financials

Next reporting dateNovember 10, 2016
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$34.0K
Annual profit (last year)-$10.2M
Net profit margin-30,067.65%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Marlborough, Massachusetts

Forecasts